Droxidopa

屈昔多巴

Report date: 2026/02/13 20:01:31
NMEFirst In Class

Base Information

Drug NameDroxidopa
Drug Alias Name屈西多巴Threo-DOPSL-threo-dihydroxyphenylserineThreo-dopaserineL-threodops +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptors agonists
TargetsAdrenergic receptors
Therapy Area/IndicationsHypotensionKidney Failure, ChronicKidney Diseases +[12] 
Global Approved IndicationsParkinson DiseaseHypotension, Orthostatic
Approved Indications in ChinaParkinson Disease
Original Approved Country/TerritoryN/A
Original Approved Date1989/01/01
Country/TerritoryCanadaUnited StatesTaiwan +[6] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesColumbia UniversityLundbeck Na LtdChongqing Shenghuaxi Pharmaceutical Ltd
Inactive CompaniesTSH Biopharm Corp LtdArizona State UniversityLoma Linda University +[4] 
Active IndicationsMenkes Kinky Hair SyndromeParkinson DiseaseHypotension, Orthostatic
Inactive IndicationsHypotensionKidney Failure, ChronicKidney Diseases +[9] 

Other Information

ATC CodeC01CA27
Related LinksWikipediaDrugBankKEGG